AI-based drug discovery firm BenevolentAI cuts SPAC deal

cafead

Administrator
Staff member
  • cafead   Dec 07, 2021 at 12:02: AM
via UK artificial intelligence specialist BenevolentAI has said it will float on the Amsterdam Euronext exchange in what is being touted as Europe’s largest ever special purpose acquisition company (SPAC) deal.

article source
 

<